The cratering of big-cap technology and tech-related S&P 500 stocks is reaching epic proportions. And amazingly, it's getting worse. Read More...
Motley Fool
Why Teva Stock Sank On Thursday
Thursday was an eventful day for drug maker Teva Pharmaceutical Industries (NYSE: TEVA). Not only did the company release its latest set of quarterly earnings, it also reached a settlement in a major lawsuit. Arguably, the more important development is the legal settlement, in which Teva has agreed to pay a total of $523 million to the state of New York.
